Capsule endoscopy systems represent 54.3% of the product type category and celiac disease accounts for 32.6% of disease indication demand in 2026. The smart pill technologies market was valued at USD 0.9 billion in 2025 and is forecast to post a 7.5% CAGR between 2026 and 2036.